Reason for request
Inscription
Clinical Benefit
| Substantial |
Le service médical rendu par PROPOFOL PANPHARMA 10 mg/mL et 20 mg/mL en émulsion injectable (IV) est important dans les indications de l’AMM.
|
Clinical Added Value
| no clinical added value |
Ces deux spécialités, génériques de DIPRIVAN, n’apportent pas d’amélioration du service médical rendu (ASMR V, inexistante).
|
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
X836Y3bqYWKbnTHP